Therefore, current standard-of-care biomarkers such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) provide important prognostic and predictive information in case of breast cancer [45]. Here, ERBB2 is linked to breast carcinoma.